Results 211 to 220 of about 3,018,484 (379)
Off-label use: Patient, surgeon & industry
Thomas S. Roukis, DPM, PhD, FACFAS
doaj +1 more source
Prevalence and characteristics of off-label use of antidepressants in paediatric patients in China. [PDF]
Zhang X +6 more
europepmc +1 more source
Comparison of minoxidil sulfotransferase activity between scalp hair, eyebrows, and eyelashes: Implication for minoxidil efficacy for off‐label use [PDF]
Nina Mehta, Andy Goren
openalex +1 more source
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
Review of Promising Off-Label Use of Deucravacitinib. [PDF]
Mima Y, Yamamoto M, Iozumi K.
europepmc +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
Off-label use of psychotropic drugs in youth. [PDF]
Rosland HG, Wergeland GJ, Holst L.
europepmc +1 more source
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
Off-label use of thalidomide in children with Crohn's disease and inflammatory bowel diseases. [PDF]
Fonseca LB +3 more
europepmc +1 more source

